Genomes and Genes


Bruce Robinson


Affiliation: University of Western Australia
Country: Australia


  1. Chee J, Robinson B, Holt R, Creaney J. Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies. Chest. 2017;151:891-897 pubmed publisher
  2. Khong A, Cleaver A, Fahmi Alatas M, Wylie B, Connor T, Fisher S, et al. The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40. BMC Cancer. 2014;14:969 pubmed publisher
    ..Both adjuvants are available for clinical use/trial, hence this treatment regimen has clear translational potential. ..
  3. Robinson C, Dick I, Wise M, Holloway A, Diyagama D, Robinson B, et al. Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma. BMC Cancer. 2015;15:983 pubmed publisher
    ..Of particular note, MexTAg mesothelioma development was not dependent on cdkn2 deletion. ..
  4. Aston W, Hope D, Nowak A, Robinson B, Lake R, Lesterhuis W. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17:684 pubmed publisher
  5. Sneddon S, Patch A, Dick I, Kazakoff S, Pearson J, Waddell N, et al. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma. BMC Cancer. 2017;17:396 pubmed publisher
  6. Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber D, et al. Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer. 2017;17:386 pubmed publisher
    ..Molecular markers like calretinin and mesothelin are promising tools to improve and supplement the diagnosis of MM and warrant further validation in a prospective study. ..